Brean Capital Reiterates Buy on Electronics for Imaging (EFII)
- Wall Street boosted by financial, tech stocks
- Oil falls on firmer dollar and profit-taking after OPEC rally
- Costco Wholesale (COST) Tops Q4 EPS by 4c; Comps Rose 3%
- Deutsche Bank woes keep stocks on steep slide
- Pre-Open Stock Movers 09/30: (LXK) (AUPH) (DB) Higher; (OPHT) (CAMP) (CTSH) Lower (more...)
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Brean Capital reiterated a Buy rating and $60.00 price target on Electronics for Imaging Inc. (NASDAQ: EFII). The Sep Q will provide both the first Q and a full Q of Organic Reggiani & Matan. Brean Capital believes that the degree to which EFI will benefit from product cycles across the board heading into 2017 isn't yet fully appreciated.
Analyst Ananda Baruah commented, "We believe that SGIA underscores what we believe is an inherent under-appreciation in the EFI story through '17. Namely, that the strength & health in the core Display Graphics segment (we believe potentially 35% - 40% of EFI revenue) remains substantive at (high-single digit organic growth), but has been masked as EFI has increasingly moved traditional VUTEK jobs to the newly acquired Reggiani platforms (Textile for soft-signage) and Matan (superior roll-to-roll tech), which has served to simultaneously capture jobs while in essence forcing down organic growth greater than anticipated. Our $60 TP reflects a 1.0x PEG (or 20x) the $3.00 in CY17 EPS we believe EFI can achieve on 10%+ organic revenue growth."
Shares of Electronics for Imaging Inc. closed at $48.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Brean Capital Assumes Nektar Therapeutics (NKTR) at Buy
- Jefferies Raises Price Target on Willis Towers Watson (WLTW) Following Investor Day
- UPDATE: Brean Capital Assumes Alder Biopharm (ALDR) at Buy
Create E-mail Alert Related CategoriesAnalyst Comments
Related EntitiesBrean Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!